mirusbio品牌介绍
品牌简介
Mirus是建立在非病毒(即基于质粒DNA)方法比病毒方法提供明显优势的基础上的。我们在1996年的初步突破来自于一种新型转染试剂的开发，该试剂结合了高效传递和低细胞毒性:TransIT®-LT1(低毒性)试剂仍然是广泛的基因传递应用的“黄金标准”。。
Mirus was founded on the principle that non-viral (i.e. plasmid DNA based) methods offer distinct advantages over viral methods of gene transfer. Our initial breakthrough in 1996 came with the development of a new type of transfection reagent that combined high efficiency delivery with low cellular toxicity: TransIT®-LT1 (Low Toxicity) Reagent remains the “gold standard” for broad-based gene delivery applications.
Main product
AAV Production
Antibiotics
Baculovirus Production
CRISPR
DNA Transfection
Electroporation
Endotoxin Removal
In Vivo Delivery
Labeling
Lentivirus Production
Media & Supplements
mRNA Transfection
Oligo
Protein Production
siRNA/miRNA Transfection
https://www.mirusbio.com
联系我们
